Sep 13, 2017 11:00 am UTC| Business
EDINBURGH, United Kingdom, Sept. 13, 2017 -- NuCana plc announced the presentation of interim first-in-human data from a Phase 1 clinical study of NUC-3373, its ProTide transformation of the active anti-cancer...
Sep 13, 2017 11:00 am UTC| Business
Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and...
Sep 13, 2017 11:00 am UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 13, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop...
ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 13, 2017 11:00 am UTC| Business
YONKERS, N.Y., Sept. 13, 2017 -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant...
Sep 13, 2017 11:00 am UTC| Business
HOLLYWOOD, Fla., Sept. 13, 2017 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, announced today that it was selected by the New...
Teekay Corporation Announces Changes to Board of Directors
Sep 13, 2017 10:55 am UTC| Business
HAMILTON, Bermuda, Sept. 13, 2017 -- Teekay Corporation (Teekay or the Company) (NYSE:TK) announced today the following changes to its Board of Directors: Axel Karlshoej, Director and Chairman Emeritus, and Thomas...
Sep 13, 2017 10:55 am UTC| Business
VANCOUVER, British Columbia, Sept. 13, 2017 -- Contact Gold Corp. (the “Company” or “Contact Gold”) (TSX-V:C) is pleased to announce that it has completed staking and acquiring an additional 270 unpatented mining claims...